Global Biopharmaceutical CMO Services Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Biopharmaceutical CMO Services Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application
Biopharmaceutical CMO Services report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Biopharmaceutical CMO Services market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Clinical Manufacturing and Commercial Manufacturing are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical CMO Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceutical CMO Services key companies include Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie, JRS Pharma, Catalent, Biomeva, Samsung BioLogics and AbbVie, etc. Lonza, Boehringer Ingelheim, AGC Biologics are top 3 players and held % share in total in 2022.
Biopharmaceutical CMO Services can be divided into Biologics Manufacturing, Biosimilars Manufacturing and Others,, etc. Biologics Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical CMO Services is widely used in various fields, such as Clinical Manufacturing, Commercial Manufacturing and Others,, etc. Clinical Manufacturing provides greatest supports to the Biopharmaceutical CMO Services industry development. In 2022, global % share of Biopharmaceutical CMO Services went into Clinical Manufacturing filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CMO Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical CMO Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical CMO Services introduction, etc. Biopharmaceutical CMO Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biopharmaceutical CMO Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.
North America, Europe and Asia Pacific are the key regions for Biopharmaceutical CMO Services industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Biopharmaceutical CMO Services key companies include Lonza, Boehringer Ingelheim, AGC Biologics, Rentschler Biotechnologie, JRS Pharma, Catalent, Biomeva, Samsung BioLogics and AbbVie, etc. Lonza, Boehringer Ingelheim, AGC Biologics are top 3 players and held % share in total in 2022.
Biopharmaceutical CMO Services can be divided into Biologics Manufacturing, Biosimilars Manufacturing and Others,, etc. Biologics Manufacturing is the mainstream product in the market, accounting for % share globally in 2022.
Biopharmaceutical CMO Services is widely used in various fields, such as Clinical Manufacturing, Commercial Manufacturing and Others,, etc. Clinical Manufacturing provides greatest supports to the Biopharmaceutical CMO Services industry development. In 2022, global % share of Biopharmaceutical CMO Services went into Clinical Manufacturing filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Biopharmaceutical CMO Services market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
Lonza
Boehringer Ingelheim
AGC Biologics
Rentschler Biotechnologie
JRS Pharma
Catalent
Biomeva
Samsung BioLogics
AbbVie
Binex
WuXi Biologics
PRA Health Sciences
ProBioGen
KBI Biopharma
Segment by Type
Biologics Manufacturing
Biosimilars Manufacturing
Others
Segment by Application
Clinical Manufacturing
Commercial Manufacturing
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Biopharmaceutical CMO Services market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Biopharmaceutical CMO Services introduction, etc. Biopharmaceutical CMO Services Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Biopharmaceutical CMO Services market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.